Use access key #2 to skip to page content.
$5.81 -0.36 (-5.83%)
1/9/2009 4:00 PM

Enzon Pharmaceuticals, Inc. (ENZN)

CAPS Rating:
****

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

View All Commentary (ENZN)

Recs

0

Avatar hennessy7 (< 20) Submitted: 5/26/08 9:12 AM : Outperform Start Price: $8.85 ENZN Score: 1.00

I like the sector. This is a sector pick as I have done little DD on this stock. I think small biotech has been hit hard, and the cancer market, in particular, is going to turn around. Plus, I do not see too many incredible investments in other sectors so I am sticking to high risk/ high reward opportunities.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links